Copyright
©The Author(s) 2021.
World J Clin Oncol. Aug 24, 2021; 12(8): 675-687
Published online Aug 24, 2021. doi: 10.5306/wjco.v12.i8.675
Published online Aug 24, 2021. doi: 10.5306/wjco.v12.i8.675
Additional metastatic lymph nodes, n = 79 | |
Age | |
< 40 | 50% |
≥ 40 | 28% |
≤ 15 mm | 85% |
> 15 mm | 49% |
Histologic type | |
Ductal carcinoma | 28% |
Lobular carcinoma | 50% |
Mucinous | 0 |
Tumor size | |
≤ 10 mm | 7% |
11-15 mm | 10% |
16-20 mm | 42% |
> 20 mm | 47% |
Grade | |
DCIS | 0 |
I | 18% |
II | 31% |
III | 45% |
Molecular subtype | |
Luminal A/B | 28% |
Basal | 55% |
HER2 | 0 |
- Citation: Herrero M, Ciérvide R, Calle-Purón ME, Valero J, Buelga P, Rodriguez-Bertos I, Benassi L, Montero A. Macrometastasis at selective lymph node biopsy: A practical going-for-the-one clinical scoring system to personalize decision making. World J Clin Oncol 2021; 12(8): 675-687
- URL: https://www.wjgnet.com/2218-4333/full/v12/i8/675.htm
- DOI: https://dx.doi.org/10.5306/wjco.v12.i8.675